Application of Omics Technologies in the Study of Antibiotic Resistance: Trends and Beyond

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Genetics and Genomics".

Deadline for manuscript submissions: closed (12 April 2024) | Viewed by 508

Special Issue Editor


E-Mail Website
Guest Editor
Department of Microbiology and Parasitology, Universidad de Sevilla, 41004 Sevilla, Spain
Interests: system biology; omics; genomic; antibiotic resistance

Special Issue Information

Dear Colleagues,

Antimicrobial resistance is a serious threat to global health and is becoming increasingly alarming due to the continued emergence of pathogens with an extraordinary ability to acquire new antibiotic resistance traits. In recent years, new multi-resistant mechanisms have emerged and spread worldwide, making current treatments increasingly ineffective against common bacteria causing serious and often fatal infections.

In this context, major efforts are needed to generate hypotheses to better understand the acquisition and evolution of antibiotic resistance. Although the main targets and mechanisms of action of most antibiotics have been identified and are well studied, it is increasingly clear that antibiotic efficacy is a very complex process that occurs at the systems level. 

Systems biology is an approach that through the use of multi-omics technologies, including genomics, transcriptomics and metabolomics, allows a holistic view of the mechanisms involved in microbial responses to antibiotic stress, thus providing a better understanding of the processes involved in the acquisition of resistance. Thus, the use of this approach constitutes a novel strategy to suggest non-obvious targets for multidrug therapies that could slow the evolution of resistance or reveal weaknesses that confer hypersensitivity to alternative treatments in evolved resistant bacteria.

In this context, this special issue invites academic scientists to submit reviews and original research articles that address the application of omics technologies focused on understanding mechanisms related to antibiotic resistance.

Dr. Francine Amaral Piubeli
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antibiotic resistance
  • genomic
  • transcriptomic
  • metabolomic
  • system biology
  • multi-omics technologies

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop